$260.00
Tirzepatide is a dual GIP and GLP-1 receptor agonist built on the GIP backbone with a C20 fatty-diacid moiety for extended action. It is studied in metabolic research for the combined incretin effects on glycemic control, appetite and body weight.
| Product Format | 40mg vials |
|---|---|
| Vial Size | 40mg |
| Vial Capacity | 3 mL |
| Box Combinations | 80mg, 200mg, 400mg |
| Cost per milligram | $7.72 – $3.25 |
| Multi-vial Purity | 99.55% |
| Endotoxin Screening | PASSED |
| Heavy Metals Screening | PASSED |
| Purity Screening | PASSED |
| Doubly Validated | YES |
| Independently Tested | YES |
Allen Biotechnology Co Manufacturer ID: WF49
Batch ID: AM202632
CAS: 2023788-19-2
Molecular Formula: C225H348N48O68
For educational purposes only.
Clinical research on tirzepatide reports greater reductions in weight and glycated hemoglobin than selective GLP-1 agonists in head-to-head trials, attributed to simultaneous engagement of GIP and GLP-1 receptors and possible GIP-mediated improvements in insulin sensitivity and lipid handling.
Tirzepatide engages two incretin receptors, and trial results suggest that the second pathway adds an effect rather than redundancy.
Design literature describes the engineered peptide's albumin-binding side chain and receptor-bias profile, which produce a roughly five-day half-life and once-weekly laboratory dosing schedules.
The same albumin-anchoring strategy used across modern incretin analogues gives tirzepatide its long action.
Tirzepatide is a dual GIP and GLP-1 receptor agonist built on the GIP backbone with a C20 fatty-diacid moiety for extended action. It is sold strictly for laboratory research use — not for human or veterinary use.
The catalog specification lists 99.55% HPLC purity. Our testing policy also requires independent endotoxin, heavy-metals and sterility screening. The current certificate table and linked PDF are samples; a production certificate must match the batch ID printed on the vial.
GLP-2 Tirzepatide (40mg vials) is offered in 80mg, 200mg, 400mg boxes (2 × 40mg vials, 5 × 40mg vials, 10 × 40mg vials), priced $260.00 to $3,090.00 — the per-mg cost falls as box size increases.
Keep sealed lyophilized vials refrigerated at 2–8°C away from light (stable 24+ months). After reconstitution with bacteriostatic water, refrigerate and use within the study-validated window, typically 30 days; never freeze reconstituted solution.
No reviews yet for this product. Purchased it for your laboratory? Email sales@allenbiotechpeptides.com to share your experience.
Every saleable batch of GLP-2 Tirzepatide must have third-party certificates. The values and linked PDF below are samples, not documents for a current saleable batch. A production certificate must match the batch ID printed on the vial.
| Sample assay | Listed laboratory | Sample result | Sample file |
|---|---|---|---|
| HPLC Purity | Janoshik Analytical | 99.55% | View sample |
| Endotoxin (LAL) | Chemtos Laboratories | PASSED | View sample |
| Heavy Metals (ICP-MS) | Chemtos Laboratories | PASSED | View sample |
NOTICE: All information provided above is strictly for educational and informational purposes. These products are research chemicals intended exclusively for laboratory research. They are not approved for human consumption; do not ingest them.
By purchasing from Allen Biotechnology Co, you acknowledge that you are acquiring research chemicals. Only qualified and licensed professionals may handle this product.
Under no circumstances may this product be used as a drug, agricultural product, pesticide, food additive or household chemical. Misrepresenting it for any of those purposes is strictly prohibited by law. All website content is provided for educational use exclusively. Any form of introduction into the human or animal body is illegal.
Allen Biotechnology Co publishes its testing policy, provides a labeled sample certificate, and offers direct research support.
